When Jane Peterson came on as CEO and president of the Keystone Symposia in April of 2014, one of her goals was to expand the organization’s global reach. A 501(c)3 nonprofit organization, the ...

The Endocrine Society, a global organization that promotes endocrinology research and clinical practice, and Keystone Symposia, a nonprofit host of conferences and symposia on a range of life science ...

SILVERTHORNE, CO - August 11, 2015 - Keystone Symposia on Molecular and Cellular Biology has received a fifth three-year grant from the Bill & Melinda Gates Foundation to help fund conferences in its ...

The conference will feature a provocative keynote address by Dr. Peter Hotez, titled "Vaccines and Immunizations in a Time of Global Boiling, Megacities, and Antiscience," addressing the growing ...

SILVERTHORNE, CO – July 19, 2012 – Keystone Symposia on Molecular and Cellular Biology is pleased to announce that it has received a fourth grant from the Bill & Melinda Gates Foundation to promote ...

A couple of months ago, Keystone Symposia hosted a community forum on Alzheimer’s disease at Colorado Mountain College in Breckenridge. The speakers were all leading research scientists drawn from the ...

Keystone Symposia on Molecular and Cellular Biology has received a 3- year grant of $2,599,679 to support an expansion of Keystone Symposia’s Global Health Series. For 35 years, Keystone Symposia has ...

Title: "GEOCM04S1 vaccine candidate maintains potent crossreactivity against original SARSCoV2 B.1 and Omicron subvariant XBB.1.5." When: June 6, 2025 at 7:30 p.m. "These presentations underscore our ...

November 6, 2009 - Keystone Symposia on Molecular and Cellular Biology is pleased to announce that it has received a second grant from the Bill & Melinda Gates Foundation to fund conferences on ...

SAN DIEGO--(BUSINESS WIRE)--Lassen Therapeutics, a biotech company developing breakthrough antibody therapeutics as potential treatments for fibrosis, rare diseases and oncology, today announced plans ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Orpheris, a clinical stage neuroscience company leveraging a novel platform technology that enables the selective delivery of therapeutic agents across the blood ...